Emmaus Life Sciences, Inc. Annual report pursuant to Section 13 and 15(d)

STOCKHOLDERS' DEFICIT (Details 3) $ / shares in Units, $ in Thousands	Dec. 31, 2019 USD ($) $ / shares	Jul. 19, 2019 USD ($) $ / shares	Jul. 17, 2019 USD ($) $ / shares	Jun. 19, 2019 $ / shares	Dec. 31, 2018 USD ($) $ / shares	Sep. 27, 2018 $ / shares	Aug. 08, 2018 $ / shares	Feb. 27, 2018 $ / shares
Class Of Warrant Or Right [Line Items]
Stock price				$ 10.30		$ 11.10	$ 11.30	$ 11.40
Valuation Technique Binomial Monte-Carlo Cliquet Option Pricing Model [Member]
Class Of Warrant Or Right [Line Items]
Stock price	$ 1.97	$ 6.86	$ 7.02		$ 9.00
Conversion feature liabilities (in thousands) \| $	$ 1	$ 6,336	$ 132		$ 7,540
Valuation Technique Binomial Monte-Carlo Cliquet Option Pricing Model [Member] \| Measurement Input, Risk Free Interest Rate [Member]
Class Of Warrant Or Right [Line Items]
Selected yield		1.79			2.51
Valuation Technique Binomial Monte-Carlo Cliquet Option Pricing Model [Member] \| Measurement Input, Price Volatility [Member]
Class Of Warrant Or Right [Line Items]
Selected yield	50.00	65.00	55.00		70.00
Valuation Technique Binomial Monte-Carlo Cliquet Option Pricing Model [Member] \| Measurement Input, Expected Term [Member]
Class Of Warrant Or Right [Line Items]
Expected life (in years)	9 months 21 days	4 years 3 months 3 days	1 year 3 months 3 days		4 years 9 months 21 days